The publisher's Country Profile report on the OTC healthcare sector in Philippines provides insights on high growth markets to target, trends in the usage of category level distribution data and companies market shares.
The Filipino OTC healthcare sector was led by traditional medicines in value terms. However, the analgesics category is forecast to register fastest value growth during 2021-2026. Drug stores & pharmacies was the leading channel for distribution of OTC healthcare products in the country. United Laboratories, Inc., Johnson & Johnson Services Inc, and Bayer Ag are the leading players in the Filipino OTC healthcare.
What else is contained?
The Filipino OTC healthcare sector was led by traditional medicines in value terms. However, the analgesics category is forecast to register fastest value growth during 2021-2026. Drug stores & pharmacies was the leading channel for distribution of OTC healthcare products in the country. United Laboratories, Inc., Johnson & Johnson Services Inc, and Bayer Ag are the leading players in the Filipino OTC healthcare.
What else is contained?
- Sector data: Overall sector value data with growth analysis for 2016-2026
- Category coverage: Value and growth analysis for Analgesics, ‘cough and cold preparations’, first aid kits, indigestion preparations, medicated skin products, ‘plasters & bandages’, topical OTC medicines, traditional medicines, ‘vitamins and minerals’ and ‘other OTC healthcare products’ with inputs on individual segment share within each category and the change in their market share forecast for 2021-2026
- Leading players: Market share of companies (in value terms) and private labels (in value terms) in 2021
- Distribution data: Percentage of sales within each category through distribution channels such as cash & carries and warehouse clubs , convenience stores, drug stores & pharmacies, food & drinks specialists, hypermarkets & supermarkets, and other general retailers
Scope
- The Filipino OTC healthcare sector accounted for value share of 25%, in Asia-Pacific in 2021
- The per capita expenditure of OTC healthcare in the Philippines was lower than both the global and regional levels in 2021
- Drug stores & pharmacies was the leading distribution channel in the Filipino OTC healthcare sector, with a value share of 701% in 2021
- United Laboratories, Inc. accounted for a value share of 363% in the Filipino OTC healthcare sector, in 2021
- Topical OTC medicines was the most consolidated category, with the top three companies accounting for a 95% value share in 2021
Reasons to Buy
- Identify high potential categories and explore further market opportunities based on detailed value and volume analysis
- Existing and new players can analyze key distribution channels to identify and evaluate trends and opportunities
- Gain an understanding of the total competitive landscape based on detailed company share analysis to plan effective market positioning
- Our team of analysts have placed a significant emphasis on changes expected in the market that will provide a clear picture of the opportunities that can be tapped over the next five years, resulting in revenue expansion
- The packaging analysis report helps manufacturers, in identifying the most commonly used packaging materials in the sector
- Analysis on key macro-economic indicators such as real GDP, nominal GDP, consumer price index, household consumption expenditure, population (by age group, gender, rural-urban split, and employed people and unemployment rate. It also includes economic summary of the country along with labor market and demographic trends
Table of Contents
Report ScopeExecutive Summary
Part 1: Market Environment
Part 2: Sector Deep Dive
Part 3: Category Deep Dive
Part 4: Distribution Analysis
Part 5: Competitive Environment
Part 6: Macroeconomic Analysis
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- United Laboratories Inc.
- Johnson & Johnson Services Inc
- Bayer Ag
- GlaxoSmithKline
- Reckitt Benckiser Group plc
- Novartis
- Sanova Pharma GesmbH
- Sanofi-Aventis SA
- Pfizer Inc.
- Zuellig Pharma (Shanghai) Pharmaceutical Service Company